ArticlemBio2025
The essential role of 2,4-dienoyl-CoA reductase for the degradation of complex fatty acid mixtures.
Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fatty acids (FAs) can be used as a carbon and energy source by most bacteria. FAs are diverse and show variations in aliphatic chain length, degree and kind of branching, and number of double bonds. After activation by a thioester link to coenzyme A (CoA), FAs are degraded by the β-oxidation machinery. The core β-oxidation enzymes can degrade most FAs, except those that bear an unsaturation at even-numbered carbons. Such FAs include the essential arachidonic and linoleic FAs of the mammalian diet. We studied the role of the 2,4-dienoyl-CoA reductase FadH in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.